{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:25:45Z","timestamp":1789086345021,"version":"build-2803163510"},"reference-count":21,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Onychomycosis accounts for 50% of nail disorders, making it one of the most prevalent fungal diseases and a therapeutic challenge. Photodynamic therapy (PDT) could constitute a therapeutic alternative, owing to its good adherence, the low probability of resistance, the lack of interaction with antimicrobials, and its favorable adverse effect profile. This retrospective observational study included all patients with a microbiological diagnosis of onychomycosis treated with PDT at Miguel Servet University Hospital, Zaragoza (Spain), between January 2013 and June 2021. The protocol consisted of pre-treatment with 40% urea for 7 days, followed by 16% methyl-aminolevulinate (MAL) for 3 h and subsequent irradiation with a red-light LED lamp (37 J\/cm2), every 1 or 2 weeks. Combined treatment with oral and\/or topical antifungals was recorded. Of the 20 patients included (mean age, 59 \u00b1 17 years), 55% were men. The most frequently detected microorganism was Trichophyton rubrum (55%). The most commonly affected location was the feet (90%): 50% of these cases were associated with tinea pedis. The median (standard deviation) number of PDT sessions was 6 (2.8). PDT was combined with systemic terbinafine (250 mg\/day) in 10 cases (in 8 cases, this was administered for only 1 month), and with topical terbinafine in 3 cases. A complete clinical response was achieved in 80% (16) of cases and microbiological cure in 60% (12). PDT is a therapeutic alternative for onychomycosis, and can be administered either in monotherapy or combined with antifungals, allowing for a reduction in the duration and possible adverse effects of antifungal treatment and achieving higher cure rates than those obtained with either treatment alone.<\/jats:p>","DOI":"10.3390\/ph15060722","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T23:55:24Z","timestamp":1655078124000},"page":"722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Combination of Photodynamic Therapy and Oral Antifungals for the Treatment of Onychomycosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-6007","authenticated-orcid":false,"given":"Alba","family":"Navarro-Bielsa","sequence":"first","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, IIS Arag\u00f3n, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Gracia-Caza\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, IIS Arag\u00f3n, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Robres","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Barbastro Hospital, 22300 Huesca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, IIS Arag\u00f3n, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Calvo-Priego","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, IIS Arag\u00f3n, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aspiroz","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Royo Villanova Hospital, 50015 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8034-3617","authenticated-orcid":false,"given":"Yolanda","family":"Gilaberte","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Miguel Servet University Hospital, IIS Arag\u00f3n, Universidad de Zaragoza, 50009 Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00128071-200001010-00002","article-title":"Onychomycosis: Treatment, quality of life, and economic issues","volume":"1","author":"Elewski","year":"2000","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: A 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Arch. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/jdv.12950","article-title":"An update on photodynamic therapies in the treatment of onychomycosis","volume":"29","author":"Simmons","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ad.2015.08.005","article-title":"Usefulness of Photodynamic Therapy in the Management of Onychomycosis","volume":"106","author":"Robres","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/jdv.13842","article-title":"Methyl aminolevulinate photodynamic therapy for onychomycosis: A multicentre, randomized, controlled clinical trial","volume":"31","author":"Gilaberte","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/120347540400800107","article-title":"Treatment of onychomycosis: Pros and cons of antifungal agents","volume":"8","author":"Gupta","year":"2004","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMcp0804878","article-title":"Clinical practice. Fungal nail disease","volume":"360","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000277762","article-title":"Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents","volume":"220","author":"Ruffieux","year":"2010","journal-title":"Dermatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1439-0507.2004.01070.x","article-title":"Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum","volume":"48","author":"Kamp","year":"2005","journal-title":"Mycoses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e14280","DOI":"10.1111\/dth.14280","article-title":"Methylene blue vs. methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: Short- and medium-term effects","volume":"33","author":"Alberdi","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e202000340","DOI":"10.1002\/jbio.202000340","article-title":"Effective photodynamic treatment of Trichophyton species with Rose Bengal","volume":"14","author":"Houang","year":"2021","journal-title":"J. Biophotonics"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Iermak, I., da Silva, A.P., Kurachi, C., Bagnato, V.S., and Inada, N.M. (2019). Raman Microspectroscopy as a Tool to Elucidate the Efficacy of Topical Formulations Containing Curcumin. Pharmaceuticals, 12.","DOI":"10.3390\/ph12010044"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101774","DOI":"10.1016\/j.pdpdt.2020.101774","article-title":"Photodynamic therapy treatment of superficial fungal infections: A systematic review","volume":"31","author":"Shen","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/phpp.12624","article-title":"Methylene blue-mediated photodynamic therapy may be superior to 5% amorolfine nail lacquer for non-dermatophyte onychomycosis","volume":"37","author":"Bowornsathitchai","year":"2021","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-0811","article-title":"Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial","volume":"90","author":"Sotiriou","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jphotobiol.2015.03.015","article-title":"Small scale trial of photodynamic treatment of onychomycosis in S\u00e3o Paulo","volume":"150","author":"Tardivo","year":"2015","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/abd1806-4841.20142197","article-title":"Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: Treatment with photodynamic therapy based on methylene blue dye","volume":"89","author":"Souza","year":"2014","journal-title":"An. Bras. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/dth.12042","article-title":"Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis","volume":"27","author":"Souza","year":"2014","journal-title":"Dermatol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/myc.13077","article-title":"Superficial fungal infections in the department of dermatology, University Hospital Jena: A 7-year retrospective study on 4556 samples from 2007 to 2013","volume":"63","author":"Gamage","year":"2020","journal-title":"Mycoses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/myc.13251","article-title":"Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice","volume":"64","author":"Reinel","year":"2021","journal-title":"Mycoses"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/6\/722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:25:18Z","timestamp":1760138718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/6\/722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ph15060722"],"URL":"https:\/\/doi.org\/10.3390\/ph15060722","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}